In breast cancer, HOXA1 knockdown inhibited cell proliferation and increased apoptosis and cell cycle arrest by influencing the aberrant expression of several cell cycle and apoptosis-associated proteins, comprising cyclin D1, B-cell lymphoma 2 (Bcl-2) and Bcl-2-like protein 4 (12). This evidence concerns the gene BCL2 and breast carcinoma.